CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead

The dual phosphatase CDC25 has recently been identified as a target for diverse triple-negative breast cancers including RB1/PTEN/P53-deficient tumors. Moreover, CDC25 inhibitors effectively synergize with PI3K inhibitors to suppress tumor growth. We discuss these findings and the challenges that li...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cell Oncol
Main Authors: Zacksenhaus, Eldad, Liu, Jeff C., Granieri, Letizia, Vorobieva, Ioulia, Wang, Dong-Yu, Ghanbari-Azarnier, Ronak, Li, Huiqin, Ali, Amjad, Chung, Philip E.D., Ju, YoungJun, Jiang, Zhe, Shrestha, Mariusz
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Author's Views
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149702/
https://ncbi.nlm.nih.gov/pubmed/30250928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1481814
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados